Chondrosarcoma, primary site

Coding note from above levels

For use of this category, reference should be made to the mortality coding rules and guidelines in the Reference Guide.

2A01.1 – Mesenchymal tumour of meninges
2A02.1 – Tumours of cranial or paraspinal nerves
http://id.who.int/icd/entity/879154182 – Neoplasms of central nervous system or related structures

Show allHide

http://id.who.int/icd/entity/944754984 – Neoplasms of haematopoietic or lymphoid tissues

2B50.0 – Chondrosarcoma of bone or articular cartilage of limbs
2B50.1 – Chondrosarcoma of bone or articular cartilage of pelvis
2B50.2 – Chondrosarcoma of bone or articular cartilage of ribs, sternum or clavicle
2B50.Y – Chondrosarcoma of bone or articular cartilage of other specified sites
2B50.Z – Chondrosarcoma of bone or articular cartilage of unspecified sites

2B51 – Osteosarcoma, primary site
2B52 – Ewing sarcoma, primary site
2B53 – Fibroblastic or myofibroblastic tumour, primary site
2B54 – Undifferentiated pleomorphic sarcoma, primary site
2B55 – Rhabdomyosarcoma, primary site
2B56 – Angiosarcoma, primary site
2B57 – Kaposi sarcoma, primary site
2B58 – Leiomyosarcoma, primary site
2B59 – Liposarcoma, primary site
2B5A – Synovial sarcoma, primary site
2B5B – Gastrointestinal stromal tumour, primary site
2B5C – Endometrial stromal sarcoma, primary site
2B5D – Malignant mixed epithelial mesenchymal tumour, primary site
2B5E – Malignant nerve sheath tumour of peripheral nerves or autonomic nervous system, primary site
2B5F – Sarcoma, not elsewhere classified, primary site
2B5G – Myosarcoma of uterus, part not specified
2B5H – Well differentiated lipomatous tumour, primary site
2B5J – Malignant miscellaneous tumours of bone or articular cartilage of other or unspecified sites
2B5K – Unspecified malignant soft tissue tumours or sarcomas of bone or articular cartilage of other or unspecified sites
2B5Y – Other specified malignant mesenchymal neoplasms
2B5Z – Malignant mesenchymal neoplasm of unspecified type

Part of: 02: Neoplasms